Indivior (INDV) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Indivior

NOTE: This is based on 102 open tips for Indivior (INDV)


Indivior (INDV)
Latest Quote Price

1,238.00p

Indivior (INDV)
Price Change (%)

2.46%


Latest Bid : 1,248.00p Latest Ask : 1,250.00p
High Today : 1,264.00p Low Today : 1,230.00p
This Years High : 1,264.00p This Years Low : 576.50p
Volume : 304,722 MKT Cap : £1547.5M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Indivior (INDV) Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Indivior (INDV) Latest Tips

Type Tipster SectorScore Start date Performance
Hold Russ Mould Premium Only 2025-06-03 05:00:00 03/06/2025 33.12%
Buy Jefferies Premium Only 2025-02-25 04:50:00 25/02/2025 52.54%
Buy Jefferies Premium Only 2025-01-03 05:36:00 03/01/2025 24.86%
Buy Jefferies Premium Only 2024-12-17 16:02:00 17/12/2024 32.83%
Buy Deutsche Bank Premium Only 2024-10-11 07:15:00 11/10/2024 115.31%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Indivior (INDV) Active Short Positions

Fund Manager Position Date
Qube Research & Technologies Limited 1.4% 04/11/2025
Citadel Advisors LLC 0.53% 26/09/2025
Millennium Capital (DIFC) Limited 1.03% 22/07/2025

See more short positions...


Latest Bid : 1,248.00p Latest Ask : 1,250.00p
High Today : 1,264.00p Low Today : 1,230.00p
This Years High : 1,264.00p This Years Low : 576.50p
Volume : 304,722 MKT Cap : £1547.5M

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Indivior Tips

Type Tipster SectorScore Start date Performance
Hold Russ Mould Premium Only 2025-06-03 05:00:00 03/06/2025 33.12%
Buy Jefferies Premium Only 2025-02-25 04:50:00 25/02/2025 52.54%
Buy Jefferies Premium Only 2025-01-03 05:36:00 03/01/2025 24.86%
Buy Jefferies Premium Only 2024-12-17 16:02:00 17/12/2024 32.83%
Buy Deutsche Bank Premium Only 2024-10-11 07:15:00 11/10/2024 115.31%